Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-23

Clinical Trial Update: VESPER: Pelvic Organ Prolapse Study [NA]

View source ↗

Summary

The VESPER study evaluating pelvic organ prolapse has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hampshire Hospitals NHS Foundation Trust | Conditions: Pelvic Organ Prolapse | NA | Status: WITHDRAWN